0.00Open0.00Pre Close0 Volume0 Open Interest950.00Strike Price0.00Turnover5448.37%IV-24.17%PremiumJan 3, 2025Expiry Date184.90Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9950Delta0.0002Gamma--Leverage Ratio-529.1971Theta0.0000Rho0.00Eff Leverage0.0002Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet